ENTITY
Johnson & Johnson

Johnson & Johnson (JNJ US)

243
Analysis
Health CareUnited States
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
more
Refresh
28 Apr 2017 14:09

The Week That Was in NorthAsia@Smartkarma - THAAD Deployment, Mobile Lineage, and Activism in Japan

KoreaScott Laprise/ 乐天虎 and Prasenjit K. Basu have provided great insights regarding the political turmoil surrounding North Korea. Scott makes it...

Logo
222 Views
Share
bearishCelltrion Inc
22 Apr 2017 02:17

The Disconnect Is Growing

Celltrion Inc (068270 KS) 's Inflectra, a biosimilar to Johnson & Johnson (JNJ US) 's Remicade, had little impact on the critical U.S. market...

Share
17 Apr 2017 06:55

The Week That Was in NorthAsia@Smartkarma: Toshiba, Peptidream, and Missiles

It's been a full week for coverage of North Asia on Smartkarma. 30-odd insights on Japan and a dozen on Korea.ToshibaThe big theme of the week, and...

Logo
Mio Kato
342 Views
Share
bullishPeptidream Inc
11 Apr 2017 21:53

PeptiDream: J&J Latest Drug Major to Tie Up

On the surface, Peptidream's (4587 JP) deal with Johnson & Johnson's (JNJ US) Janssen unit looks no different from the deals they have cut with...

bullishActelion Ltd
10 Apr 2017 15:54

Actelion / Johnson & Johnson: Trading Idorsia, the R&D NewCo Spin-Off

J&J recent declared its tender offer for Actelion successful and we are now in the midst of the additional acceptance period which runs from...

Share
x